A. Chiarini; M. Micucci; M. Malaguti; R. Budriesi; P. Ioan; M. Lenzi; C. Fimognari; T. Gallina Toschi; P. Comandini; S. Hrelia, Sweet chestnut (Castanea Sativa Mill.) bark extract: cardiovascular activity and myocyte protection against oxidative damage, «OXIDATIVE MEDICINE AND CELLULAR LONGEVITY», 2013, 2013, Article number: 471790 , pp. 1 - 10 [Scientific article]Open Access
Sestili P; Paolillo M; Lenzi M; Colombo E; Vallorani L; Casadei L; Martinelli C; Fimognari C., Sulforaphane induces DNA single strand breaks in cultured human cells., «MUTATION RESEARCH. FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS», 2010, 689, pp. 65 - 73 [Scientific article]
FIMOGNARI C.; M. LENZI; G. CANTELLI FORTI; P. HRELIA, Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells., «ANNALS OF THE NEW YORK ACADEMY OF SCIENCES», 2009, 1171, pp. 264 - 269 [Scientific article]
Fimognari C.; Lenzi M.; Hrelia P., Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells., «ENVIRONMENTAL AND MOLECULAR MUTAGENESIS», 2009, 50, pp. 171 - 189 [Scientific article]
FIMOGNARI C.; M. LENZI; G. CANTELLI FORTI; P. HRELIA, Cytotoxicity of Hemidesmus indicus extract is associated with apoptosis by activation of mitochondrial pathway and interruption of cell-cycle progression by modulation of cyclin A2 and P21 in human jurkat T cells., in: Libro degli Abstracts, MILANO, Società Italiana di Farmacologia, 2009, pp. - - - (atti di: 34° Congresso Nazionale della Società Italiana di Farmacologia, Rimini, 14-17 Ottobre 2009) [Abstract]
FIMOGNARI C.; P. SESTILI; M. LENZI; G. CANTELLI FORTI; P. HRELIA, Protective effect of creatine against RNA damage., «MUTATION RESEARCH», 2009, 670, pp. 59 - 67 [Scientific article]
Fimognari C.; Lenzi M.; Hrelia P., Chemoprevention of Cancer by Isothiocyanates and Anthocyanins: Mechanisms of Action and Structure-Activity Relationship, «CURRENT MEDICINAL CHEMISTRY», 2008, 15, pp. 440 - 447 [Scientific article]
Fimognari C.; Lenzi M.; Cantelli-Forti G.; Hrelia P., Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane., «IN VIVO», 2008, 22(3), pp. 317 - 320 [Scientific article]
Fimognari C.; Lenzi M.; Hrelia P., Interaction of the isothiocyanate sulforaphane with drug disposition and metabolism: pharmacological and toxicological implications., «CURRENT DRUG METABOLISM», 2008, 9(7), pp. 668 - 678 [Scientific article]
Fimognari C.; Sestili P.; Lenzi M.; Bucchini A.; Cantelli-Forti G.; Hrelia P., RNA as a new target for toxic and protective agents., «MUTATION RESEARCH. FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS», 2008, 648(1-2), pp. 15 - 22 [Scientific article]
Fimognari C.; Lenzi M.; Sciuscio D.; Cantelli-Forti G.; Hrelia P., Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells., «IN VIVO», 2007, 21, pp. 377 - 380 [Scientific article]
Fimognari C.; Lenzi M.; Sciuscio D.; Cantelli Forti G.; Hrelia P., Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation., «ANNALS OF THE NEW YORK ACADEMY OF SCIENCES», 2007, 1095, pp. 62 - 69 [Scientific article]
Fimognari C.; Lenzi M.; Cantelli-Forti G.; Hrelia P., Isothiocyanates as promising chemopreventive and antioxidant agents, in: New developments in antioxidants research, NEW YORK, Nova Science Publisher, 2006, pp. 43 - 59 (Nova Biomedical) [Chapter or essay]
Fimognari C.; Nuesse M.; Lenzi M.; Sciuscio D.; Cantelli-Forti G.; Hrelia P., Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations., «MUTATION RESEARCH. FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS», 2006, 601, pp. 92 - 101 [Scientific article]
